- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Malta
Total 137 results
-
Union College, New YorkSkidmore CollegeCompleted
-
Centocor, Inc.Schering-PloughCompletedRheumatoid ArthritisAustralia, Poland, Ukraine, United States, Argentina, Colombia, New Zealand, Peru, Mexico, Germany, Hungary, Lithuania, Malaysia, Latvia, Malta
-
University of Southern CaliforniaNational Cancer Institute (NCI); New York UniversityCompletedGastric Cancer | Gastric AdenocarcinomaUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe DiseaseUnited States
-
PfizerInternational Collaborative Cancer GroupCompletedBreast NeoplasmsAustralia, Denmark, Netherlands, United States, Bulgaria, Hungary, Italy, Spain, Belgium, Czech Republic, Ireland, Poland, Russian Federation, Sweden, United Kingdom, Croatia, Serbia, Germany, Bosnia and Herzegovina, Norway, South... and more
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease | Glycogenesis 2 Acid Maltase DeficiencyUnited States, Canada, Australia
-
Laval UniversityCanadian Lung AssociationUnknownPulmonary Disease, Chronic ObstructiveCanada
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, France, Germany, Israel, Italy, Netherlands, Taiwan
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2Netherlands
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Glycogenosis 2United States
-
Genzyme, a Sanofi CompanyCompletedGlycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)France
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2France
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II | Glycogenosis 2
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States, Israel, France, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, Taiwan, Israel, United Kingdom, France
-
Hôpital Armand TrousseauCompletedPain | Analgesia | Sedation | Intesive Care | Intratracheal VentilationSpain, United Kingdom, France, Norway, Finland, Germany, Portugal, Netherlands, Belgium, Italy, Sweden, Greece, Poland, Austria, Cyprus, Estonia, Lithuania, Malta
-
Newron Pharmaceuticals SPACompletedIdiopathic Parkinson's DiseaseUnited States, Spain, Brazil, Peru, Colombia, Germany, Argentina, India, Croatia, Czech Republic, Italy, South Africa, Finland, Portugal, Canada, Slovakia, Bulgaria, Chile, Mexico, Poland
-
Laval UniversityUniversité de MontréalUnknownDyspnea | Severe Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseCanada
-
Fundació Institut de Recerca de l'Hospital de la...Genzyme, a Sanofi CompanyUnknown
-
International Atomic Energy AgencyCompletedNon Small Cell Lung CancerChile, China, Croatia, Egypt, India, Malaysia, Malta, Morocco, Pakistan, Panama, Peru, South Africa, Tunisia
-
Laval UniversityMaltais, Francois, M.D.; Saey, Didier, M.D.; Dr Louis Laviolette; Dr Thomas SimilowskiUnknownChronic Obstructive Pulmonary DiseaseCanada
-
Eli Lilly and CompanyDuke Clinical Research Institute; Daiichi Sankyo Co., Ltd.CompletedAcute Coronary SyndromeArgentina, Brazil, Canada, Italy, China, Puerto Rico, Australia, Romania, Russian Federation, France, Germany, United States, Belgium, Bulgaria, Poland, Ukraine, United Kingdom, Colombia, Hungary, Philippines, Croatia, Denmark, India, Chil... and more
-
PfizerCompletedBreast Neoplasms | Neoplasm MetastasisUnited States, Ukraine, Russian Federation, Hong Kong, France, Australia, Poland, Malta
-
University of CopenhagenCompleted
-
Medtronic Cardiac Rhythm and Heart FailureCompletedHeart FailureUnited States, France, Poland, Taiwan, Malaysia, Romania, China, Puerto Rico, Thailand, India, Canada, Pakistan, Hong Kong, Germany, Malta, Singapore
-
European Organisation for Research and Treatment...CompletedProstate CancerNetherlands, Belgium, Israel, Malta, Russian Federation, Turkey, United Kingdom
-
AstraZenecaCompletedRheumatoid ArthritisBulgaria, Czech Republic, Poland, Russian Federation, Hungary, Romania, Ukraine, Slovakia, South Africa, Serbia, Colombia, Italy, Latvia, Malta
-
Laval UniversityMcGill University; Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseCanada
-
AstraZenecaCompletedHypertensionRussian Federation, Latvia, Romania, Slovakia, Belgium, Malta
-
Ineos Healthcare LimitedTerminatedChronic Kidney FailureUnited States, Canada, Australia, New Zealand, Brazil, France, Germany, Malta, Poland, South Africa, Spain
-
BayerCompletedHypogonadism | MaleGermany, Indonesia, Korea, Republic of, Malaysia, Saudi Arabia, Singapore, Spain, Thailand, Philippines, Taiwan, Australia, Austria, Bulgaria, Colombia, Czech Republic, Estonia, Hong Kong, Italy, Jordan, Kazakhstan, Latvia, Lebanon, Lithuani... and more
-
Hisamitsu Farmaceutica do Brasil LtdaUnknownPain | Myalgia | Sprains | Contusions | Tendonitis
-
Solvay PharmaceuticalsCompletedParkinson's DiseaseBulgaria, Malta, Serbia
-
National Institute of Arthritis and Musculoskeletal...CompletedMyositis | Dermatomyositis | Polymyositis | Glycogen Storage Disease Type II | Glycogen Storage Disease Type VIIUnited States